Taysha Gene Therapies, Inc.
TSHA
Revenue
1.11M
▼-2.30M▼-67.40%
3 Months ChangeAssets
200.39M
▲47.39M▲30.98%
3 Months ChangeLiabilities
91.53M
▼-7.63M▼-7.69%
3 Months ChangeFree Cash Flow
-19.94M
▲4.15M▲17.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0000950170-24-095082
2024-08-12
Form 8-K
ID: 0001193125-24-198392
2024-06-26
Form 8-K
ID: 0001193125-24-169191
2024-06-26
Form 8-K
ID: 0001193125-24-168479
2024-06-18
Form 8-K
ID: 0001193125-24-163050
2024-05-30
Form 8-K
ID: 0001193125-24-150323
2024-05-14
Form 8-K
ID: 0001193125-24-138253
2024-05-14
Form 10-Q
ID: 0000950170-24-059555
2024-03-19
Form 8-K
ID: 0001193125-24-071321
2024-01-10
Form 8-K
ID: 0001193125-24-005637